Fresolimumab
CAS: 948564-73-6
Ref. TM-T76681
| 1mg | 554.00 € | ||
| 5mg | 1,559.00 € | ||
| 10mg | 2,487.00 € | ||
| 25mg | 3,650.00 € | ||
| 50mg | 4,983.00 € |
Estimated delivery in United States, on Wednesday 6 Nov 2024
Product Information
Name:
Fresolimumab
Synonyms:
- GC1008
- GC 1008
- Immunoglobulin G4, anti-(transforming growth factor β) (human monoclonal GC-1008 heavy chain), disulfide with human monoclonal GC-1008 light chain, dimer
Description:
Fresolimumab (GC1008) is a human monoclonal antibody targeting active TGFβ1, TGFβ2, TGFβ3, studied for cancer and focal segmental glomerulosclerosis.
Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:
Chemical properties
Purity:
95% - SDS-PAGE:95% SEC-HPLC:95%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:
Technical inquiry about: TM-T76681 Fresolimumab
Please use instead the cart to request a quotation or an order
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
